Clinical Trials Browser

Phase 1 × Goserelin × 90 days × Clear all

NCT05617885 2026-02-27

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Phase 1 Active not recruiting

Prostatic Neoplasms